Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Nasopharyngeal Neoplasms × Clear all

Phase

Phase 2 8 Phase NA 3 Phase 1/2 2 Phase 1 2 Phase 4 1 Phase 3 1

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 31 Prostatic Neoplasms 13 Neoplasms 13 Multiple Myeloma 9 Carcinoma, Hepatocellular 9 Colorectal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Papillomavirus Infections 7 Lung Neoplasms 7 Stomach Neoplasms 6 Pain, Postoperative 6 Liver Neoplasms 5 Recurrence 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Kidney Neoplasms 4 Heart Failure 4 Warts 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Skin Neoplasms 3 Pituitary Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Neuroendocrine Tumors 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Febrile Neutropenia 3

Interventions

toripalimab 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06457503 2026-03-02

TRANSPARENT

Coherus Oncology, Inc.

Phase 4 Recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡